Results 251 to 260 of about 48,917 (272)

Progressive Multifocal Leukoencephalopathy

European Neurology, 1971
The present paper reports on a case of progressive multifocal leukoencephalopathy, with certain particularities.
C, Arseni, F, Nerean tiu
openaire   +2 more sources

Pediatric inflammatory leukoencephalopathies

Acquired demyelinating syndromes (ADS) represent acute neurologic illnesses characterized by deficits persisting for at least 24hours and involving the optic nerve, brain, or spinal cord, associated with regional areas of increased signal on T2-weighted images.
Omar, Abdel-Mannan, Yael, Hacohen
openaire   +2 more sources

Inherited Leukoencephalopathiesa

Seminars in Neurology, 2012
Abstract Leukoencephalopathies are disorders that selectively involve the white matter of the brain. Acquired causes of leukoencephalopathy include inflammatory, infectious, vascular, neoplastic, and toxic disorders. Hereditary leukoencephalopathies encompass conditions characterized by progressive destruction or loss of previously ...
openaire   +2 more sources

Leukoencephalopathies in Adulthood

Seminars in Neurology, 2012
The understanding of the genetic basis of late-onset leukoencephalopathies has continued to increase in recent years. The most commonly presenting leukoencephalopathies in adulthood can be late-onset manifestations of metabolic pathways.
Jan-Mendelt, Tillema, Deborah L, Renaud
openaire   +2 more sources

Acquired perinatal leukoencephalopathy

Annals of Neurology, 1984
AbstractBetween 36 and 44 weeks after conception, telencephalic white matter in the newborn appears to be particularly vulnerable to insults that result in morphological disturbances. Available evidence indicates that this disorder (or group of disorders), named acquired perinatal leukoencephalopathy, reflects a decrease in blood flow through the ...
A, Leviton, F H, Gilles
openaire   +2 more sources

Intracarotid BCNU leukoencephalopathy

Cancer, 1986
Intracarotid 1,3-bis(2-chloroethyl)-1-nitrosurea (BCNU) is now a frequently used chemotherapeutic agent for high-grade glial neoplasms. The toxicity from such therapy has not been well-documented. A 50-year-old man with a left frontoparietal grade 4 astrocytoma received three injections of intracarotid BCNU, 400 mg each, over a 2-month period.
openaire   +2 more sources

Progressive multifocal leukoencephalopathy

Journal of Neuroimmunology, 2011
Progressive multifocal leukoencephalopathy (PML) is a disease of the central nervous system (CNS) with destructive infection of oligodendrocytes by JC virus. PML belongs to the opportunistic infections. It is observed in patients with HIV infection, lymphoid malignancies, after organ- and stem cell transplantations and more recently in the context of ...
openaire   +2 more sources

Adult inflammatory leukoencephalopathies

Inflammatory white matter disorders may commonly mimic genetic leukoencephalopathies. These include atypical presentations of common conditions, such as multiple sclerosis, together with rare inflammatory disorders. A structured approach to such cases is essential, together with judicious use of the many available diagnostic biomarkers.
Thomas, Williams, Nevin, John, Anisha, Doshi, Jeremy, Chataway   +3 more
openaire   +2 more sources

Toxic Leukoencephalopathy

New England Journal of Medicine, 2001
C M, Filley, B K, Kleinschmidt-DeMasters
openaire   +2 more sources

Capecitabine leukoencephalopathy

Practical Neurology, 2019
Zeid, Yasiry, Mahdia S, Obeda, Ruth, Batty, Basil, Sharrack   +3 more
openaire   +2 more sources